Home › Funds › BAKER BROS. ADVISORS LP › ARWR
BAKER BROS. ADVISORS LP position in ARWR
ARROWHEAD PHARMACEUTICALS IN · Health Care
BAKER BROS. ADVISORS LP reported holding 1,992,783 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$162.4M, representing 0.85% of its reported portfolio and ranking #19 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed ARWR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's ARWR position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in ARWR in Q2 2025 at 939,174 shares (US$14.8M). The position peaked in Q2 2026 at 1,992,783 shares, worth US$162.4M. Across 5 filings, BAKER BROS. ADVISORS LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,992,783 shares valued at US$162.4M. Notable position changes include a 78% increase in Q3 2025 (shares rose 92% over the following quarter), a 30% increase in Q4 2025 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 939.17K | $14.84M | New |
| Q3 2025 | 1.67M | $57.62M | Add |
| Q4 2025 | 2.18M | $144.44M | Add |
| Q1 2026 | 1.99M | $124.95M | Reduce |
| Q2 2026 | 1.99M | $162.43M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARWR and 13F data
ARWR (ARROWHEAD PHARMACEUTICALS IN) is a Health Care company. 52 other funds we track also report a position in ARWR — the largest reported positions include Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), Siren, L.L.C. (US$139.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARWR
- Avoro Capital Advisors LLC 11.36M sh · $925.59M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 3.30M sh · $269.14M · Q2 2026
- Siren, L.L.C. 1.72M sh · $139.83M · Q2 2026
- Vestal Point Capital, LP 1.57M sh · $128.38M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.39M sh · $113.22M · Q2 2026
- DRIEHAUS CAPITAL MANAGEMENT LLC 1.35M sh · $110.08M · Q2 2026
- Hood River Capital Management LLC 1.12M sh · $91.35M · Q2 2026
- SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 830.25K sh · $67.67M · Q2 2026
- Western Financial Corp/CA 820.24K sh · $53.68M · Q3 2026
- READYSTATE ASSET MANAGEMENT LP 25.00M sh · $29.94M · Q2 2026
- MACKAY SHIELDS LLC 27.19M sh · $27.84M · Q3 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held ARWR?
BAKER BROS. ADVISORS LP has disclosed ARWR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is BAKER BROS. ADVISORS LP's current position in ARWR?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 1.99M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $162.43M, representing 0.85% of its reported portfolio and ranking #19.
Has BAKER BROS. ADVISORS LP been buying or selling ARWR?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP held unchanged its position in ARWR. The position peaked in Q2 2026 at 1.99M shares.
Which other funds hold ARWR?
Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, Siren, L.L.C., among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.